Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lang

Showing results (391-400 of 437) with videos related to

Pageof 44
Sort By:
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
ESC Heart Failure|May 8, 2024
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and designJaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Circulation|October 5, 2023
Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled TrialNovalia P Sidik, Bethany Stanley, Robert Sykes, et al.
European Journal of Heart Failure|September 12, 2025
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-OncologyKalliopi Keramida, Teresa Lopez-Fernandez, Markus S Anker, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
European Heart Journal|November 30, 2018
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibilityKatja E Odening, Ilona Bodi, Gerlind Franke, et al.
Cardiovascular Research|July 24, 2020
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) studyKenneth Mangion, Andrew Morrow, Catherine Bagot, et al.
European Journal of Heart Failure|May 14, 2024
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HFJames P Curtain, Atefeh Talebi, Alasdair McIntosh, et al.
Physical Review Letters|November 13, 2003
a+0 (980)-resonance production in pp-->dK+K-0 reactions close to thresholdV Kleber, M Büscher, V Chernyshev, et al.
Physical Review Letters|March 24, 2005
Measurement of the analyzing power in p-->d-->(p p)n with a fast forward 1S0 proton pairS Yaschenko, S Dymov, A Kacharava, et al.
Pageof 44

Showing results (391-400 of 437) with videos related to

Sort By:
Pageof 44
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
ESC Heart Failure|May 8, 2024
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and designJaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Circulation|October 5, 2023
Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled TrialNovalia P Sidik, Bethany Stanley, Robert Sykes, et al.
European Journal of Heart Failure|September 12, 2025
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-OncologyKalliopi Keramida, Teresa Lopez-Fernandez, Markus S Anker, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
European Heart Journal|November 30, 2018
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibilityKatja E Odening, Ilona Bodi, Gerlind Franke, et al.
Cardiovascular Research|July 24, 2020
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) studyKenneth Mangion, Andrew Morrow, Catherine Bagot, et al.
European Journal of Heart Failure|May 14, 2024
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HFJames P Curtain, Atefeh Talebi, Alasdair McIntosh, et al.
Physical Review Letters|November 13, 2003
a+0 (980)-resonance production in pp-->dK+K-0 reactions close to thresholdV Kleber, M Büscher, V Chernyshev, et al.
Physical Review Letters|March 24, 2005
Measurement of the analyzing power in p-->d-->(p p)n with a fast forward 1S0 proton pairS Yaschenko, S Dymov, A Kacharava, et al.
Pageof 44